Articles Tagged ‘drug’

New options and benefits regarding breast cancer treatment presented at ASCO

Sentinel lymph node biopsy. First of three panel illustration showing radioactive substance and/or blue dye is injected near the tumor, the injected material is followed visually or with a probe, and the first lymph nodes to take up the material are removed and checked for cancer cells.

Results from four separate clinical trials presented at ASCO this year should change clinical practice and could spare many women the side effects of some common cancer therapies.

Clinical Trial Design and the Future of Cancer Clinical Trials

Portrait of Dr. James Doroshow, Director, Division of Cancer Treatment and Diagnosis. Credit: NCI, Ernie Branson; Photographer

At the opening presidential session of the 2010 annual meeting of the American Society of Clinical Oncology in Chicago, NCI Director John E. Niederhuber, M .D., gave an introduction to James H. Doroshow, M.D., director of NCI’s Division of Cancer Treatment and Diagnosis. It was Dr. Niederhuber’s task to present the multiple achievements that Dr. Doroshow has brought to advancing clinical trial reform and development at NCI.

The Financial Burden of Cancer

Credit: Rhoda Baer (Photographer), NCI

Cancer care cost the American public $104.1 billion in 2006 – the most recent year for which statistics are available – according to NCI’s newly released Cancer Trends Progress Report-2009/2010 Update. The financial burden of cancer looms even larger, however, when you consider other costs, such as losses in time and economic productivity.